Elevian Launches to Develop Regenerative Medicines for Age-Related Diseases

Sep 11, 2018

Elevian Launches to Develop Regenerative Medicines for Age-Related Diseases

Posted by Michael Greve in categories: biotech/medical, life extension, Peter Diamandis

Happy to announce our support for Elevian together with BOLD Capital and Peter Diamandis.

Commercializing scientific breakthroughs from Elevian’s scientific co-founders.

Comments are closed.

GETAS THREAT LEVEL: GUARDED
TOP DONOR: BRIAN CARTMELL
#2 DONOR: DONALD MACLEAN
#3 DONOR: JEFF BONE/TOPSIGHT FUND
#4 DONOR: PEG KAY

LF FUND: $594,573.68
BITCOIN ENDOWMENT: $7,199,489.52
A-PRIZE: $30,013.00
NANOSHIELD: $17,018.00
X-RISKS NETWORK: $3,108.00
AISHIELD: $4,112.00

LIFEBOAT NEWS: 3,016 SUBSCRIBERS
GETAS ALERTS: 436 SUBSCRIBERS
BLOG: 48,519 POSTS
BOARDS: 2,843 MEMBERS
REPORTS: 55
PROGRAMS: 25
FORUMS: 13
QUOTES: 136

FACEBOOK: 8,341 MEMBERS
LINKEDIN: 1,983 MEMBERS
TWITTER FEED: 33,526 MEMBERS
FIGHT AIDS: 3 MEMBERS
[email protected]: 15 MEMBERS
[email protected]: 44 MEMBERS
A-PRIZE: 55 MEMBERS
NANOSHIELD: 69 MEMBERS
AISHIELD: 25 MEMBERS

DONORS: 3,923
LF-500: 13 MEMBERS
PATRON: 1 MEMBER
FIRST CLASS: 1 MEMBER
EXECUTIVE: 12 MEMBERS
ECONOMY: 23 MEMBERS
A-500: 1 MEMBER

© 2002–2020 Lifeboat Foundation